Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

SLN Silence Therapeutics PLC

6,54

0,20 (3,15%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Silence Therapeutics Charts.

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Silence Therapeutics Charts.

News Silence Therapeutics PLC

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 9 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Montag 9 Dezember 2024 (2 Wochen vor) • Business Wire

Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
Dienstag 26 November 2024 (4 Wochen vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 18 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
Montag 18 November 2024 (1 Monat vor) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Donnerstag 14 November 2024 (1 Monat vor) • Business Wire

Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference
Mittwoch 13 November 2024 (1 Monat vor) • Business Wire

Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
Dienstag 27 August 2024 (4 Monate vor) • Business Wire

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Donnerstag 15 August 2024 (4 Monate vor) • Business Wire

Weitere Silence Therapeutics PLC News-Artikel

Euro vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen